of State of the Art Radiolabeling Facilities for 2013
require a high degree of confidence in the identity, quality and purity of
their radiolabeled, stable isotope labeled or non-labeled research compounds
will appreciate the NMR, mass spectrometry and HPLC documented catalog and
custom synthesized compounds offered by Moravek Biochemicals.
facilities have recently been expanded to 26,000 square feet. 56 fume hoods
are installed in six radiosynthesis laboratories, one stable isotope
laboratory and a radio-GMP suite. Two Bruker Avance NMR's, six mass
spectrometers, and thirty four HPLCs support the synthesis, structural
confirmation and analysis of your compound.
Capabilities, Facilities and Equipment Report
We have developed our cGMP program to follow the ICH Q7A, Good Manufacturing
Practice Guidance for Active Pharmaceutical Ingredients, Section 19, API's
for Use in Clinical Trials. Moravek Biochemicals has a cGMP program for
custom radiosynthesis that provides GMP compliance and the quality assurance
for use in clinical trials.